未登录

M

Martino Monteverde

unicancer

H指数:20

被引数:1,152

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TRANSLATE: Activation of immune response in refractory patients to standard treatment

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

Treatment outcome under cetuximab-based therapy and individual ADCC capability in head and neck cancer

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-010

OAAI

The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2015-08-0147

PREAI

Variable impact of chemotherapy+1-cetuximab on immune modulation in a prospective cohort of 163 cancer patients

CANCER RESEARCH

IF16.6

2015-08-011

PRE

Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC)

ANNALS OF ONCOLOGY

IF65.4

2015-06-010

OAAI

Prognostic and predictive biomarkers related to p53 pathway and clinical outcome in platinum-treated locally advanced head and neck cancer - A revision after > 10 years of a monocentric patient's population

IF3.9

2015-05-010

PREAI

Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines

INVESTIGATIONAL NEW DRUGS

IF2.7

2015-01-2235

PREAI

HPV16 detection by PCR in serum of HNSCC patients and comparison with primary tumour tissue

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Combination of PI3KCA targeting with irradiation: A preclinical study on head and neck cancer cell lines

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer

IF3.9

2012-10-0146

PREAI

The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma

BRITISH JOURNAL OF CANCER

IF6.8

2012-09-0618

OA

Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse

BRITISH JOURNAL OF CANCER

IF6.8

2012-07-1014

OA

MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer

IF3.9

2012-07-0111

PREAI

NT5E CpG island methylation is a favourable breast cancer biomarker

BRITISH JOURNAL OF CANCER

IF6.8

2012-05-3137

OA

Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas

BRITISH JOURNAL OF CANCER

IF6.8

2012-05-2930

OA

NT5E promoter methylation is a favorable breast cancer epigenetic biomarker

CANCER RESEARCH

IF16.6

2012-04-010

PRE

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

BRITISH JOURNAL OF CANCER

IF6.8

2012-03-2782

OAAI

Prediction of Anthracycline Cardiotoxicity after Chemotherapy by Biomarkers Kinetic Analysis

CARDIOVASCULAR TOXICOLOGY

IF3.7

2011-12-2229

PRE

High frequency of complex TP53 mutations in CNS metastases from breast cancer

BRITISH JOURNAL OF CANCER

IF6.8

2011-12-2033

OAAI